SEC Form 4 · accession 0001209191-16-152160
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chris Storgard
Officer — Chief Medical Officer
Period of report
Nov 23, 2016
Accepted (ET)
Nov 28, 2016 · 3:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 23, 2016 | P | 37,593 | $2.66 | A | 37,593 | I | By The Storgard Family Trust, June 28, 2012 |
| Common Stock | holding | — | — | — | 9,090 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.
- F2These shares are owned of record by The Storgard Family Trust, June 28, 2012 for which Chris M. Storgard and Melinda Storgard are co-trustees.